EDITAS MEDICINE, INC. Increase (Decrease) in Contract with Customer, Liability
EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Contract with Customer, Liability of -$8.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$8.19M.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$9.70M.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was -$15.92M.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$8.46M.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$3.33M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$8.19M 10-Q · filed 2026-08-05 | -$17.89M derived: sum of 3 quarters · filed 2026-08-05 | -$17.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | -$9.70M derived: sum of 2 quarters · filed 2026-05-05 | -$9.70M derived: sum of 3 quarters · filed 2026-05-05 | -$11.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$9.70M derived: sum of 2 quarters · filed 2026-03-09 | -$11.70M derived: sum of 3 quarters · filed 2026-08-05 | -$15.92M 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$2.00M derived: sum of 2 quarters · filed 2026-08-05 | -$6.22M 10-Q · filed 2025-11-10 | -$14.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$6.22M 10-Q · filed 2026-08-05 | -$14.68M derived: sum of 3 quarters · filed 2026-08-05 | -$14.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$4.22M 10-Q · filed 2026-05-05 | -$12.68M derived: sum of 2 quarters · filed 2026-05-05 | -$12.68M derived: sum of 3 quarters · filed 2026-05-05 | -$12.68M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$8.46M derived: sum of 2 quarters · filed 2026-03-09 | -$8.46M derived: sum of 3 quarters · filed 2026-03-09 | -$8.46M 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 10-K · filed 2025-03-05 | ||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-03 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $2.18M derived: sum of 3 quarters · filed 2025-03-05 | -$3.33M 10-K · filed 2025-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $2.18M derived: sum of 2 quarters · filed 2023-11-03 | -$3.33M 10-Q · filed 2023-11-03 | -$14.67M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$3.33M 10-Q · filed 2023-08-02 | -$14.67M derived: sum of 3 quarters · filed 2024-02-28 | -$20.33M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$5.52M 10-Q · filed 2023-05-05 | -$16.85M derived: sum of 2 quarters · filed 2024-02-28 | -$22.52M derived: sum of 3 quarters · filed 2024-02-28 | -$22.67M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$11.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$17.00M derived: sum of 2 quarters · filed 2024-02-28 | -$17.15M derived: sum of 3 quarters · filed 2024-02-28 | -$22.71M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$5.82M derived: sum of 2 quarters · filed 2022-11-02 | -$11.37M 10-Q · filed 2022-11-02 | -$17.14M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$5.71M 10-Q · filed 2022-08-03 | -$11.47M derived: sum of 3 quarters · filed 2023-02-22 | -$90.13M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$5.55M 10-Q · filed 2022-05-04 | -$11.32M derived: sum of 2 quarters · filed 2023-02-22 | -$89.97M derived: sum of 3 quarters · filed 2023-02-22 | -$93.04M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$5.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$84.42M derived: sum of 2 quarters · filed 2023-02-22 | -$87.48M derived: sum of 3 quarters · filed 2023-02-22 | -$91.79M 10-K · filed 2023-02-22 |
| 2020-09-30 | -$78.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$81.72M derived: sum of 2 quarters · filed 2021-11-09 | -$86.03M 10-Q · filed 2021-11-09 | -$27.70M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$7.38M 10-Q · filed 2021-08-05 | $50.95M derived: sum of 3 quarters · filed 2022-02-24 | $47.40M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$4.31M 10-Q · filed 2021-05-06 | $54.01M derived: sum of 2 quarters · filed 2022-02-24 | $50.47M derived: sum of 3 quarters · filed 2022-02-24 | $53.15M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $58.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $54.77M derived: sum of 2 quarters · filed 2022-02-24 | $57.46M derived: sum of 3 quarters · filed 2022-02-24 | $55.40M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$867.00K derived: sum of 2 quarters · filed 2020-11-06 | -$2.93M 10-Q · filed 2020-11-06 | $15.57M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $621.00K 10-Q · filed 2020-08-07 | $19.12M derived: sum of 3 quarters · filed 2021-02-26 | $19.63M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$2.06M 10-Q · filed 2020-05-08 | $16.44M derived: sum of 2 quarters · filed 2021-02-26 | $16.95M derived: sum of 3 quarters · filed 2021-02-26 | $23.97M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $19.01M derived: sum of 2 quarters · filed 2021-02-26 | $26.03M derived: sum of 3 quarters · filed 2021-02-26 | $22.89M 10-K · filed 2021-02-26 |
| 2018-09-30 | $511.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $7.53M derived: sum of 2 quarters · filed 2019-11-12 | $4.39M 10-Q · filed 2019-11-12 | $1.26M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $3.88M 10-Q · filed 2019-08-07 | $750.00K derived: sum of 3 quarters · filed 2020-02-26 | |
| 2018-03-31 | -$3.14M 10-Q · filed 2019-05-08 | -$6.27M derived: sum of 2 quarters · filed 2020-02-26 | ||
| 2017-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $81.71M 10-K · filed 2020-02-26 | ||
| 2017-09-30 | $84.83M 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $935.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |